IGI Therapeutics SA, a wholly-owned subsidiary of Ichnos Glenmark Innovation (IGI)—an alliance between Glenmark Pharma and Ichnos Sciences Inc.—has signed an exclusive licensing agreement with AbbVie ...

Biopharma company AbbVie will acquire Capstan Therapeutics for up to $2.1 billion in cash, giving it access to promising new ...

Rohinton Sidhwa, Partner, Deloitte India, said that R&D boosts innovation and has a remarkable effect on the competitive advantage of its small business ecosystem. “MSMEs depend on inputs that help ...

The last few years have seen a huge increase in currency-related costs and fractured trade relations. Locally sourced R&D can give MSMEs and startups a huge advantage,” he says.

For AI to become an effective team player with humans, it needs to develop what psychologists call theory of mind—in R&D, this would mean an understanding of scientists’ often tacit objectives. Kaski ...

AbbVie has multiple growth narratives to offset HUMIRA losses and clinical trial failures (e.g., venetoclax in MDS). In Q1, SKYRIZI generated a whopping $3.425 billion in net revenues ...

News Release 17-Jun-2025 A revolution for R&D with the missing link of machine learning — project envisions human-AI expert teams to solve grand challenges ...

AbbVie is undervalued with strong EPS growth, rising immunology revenue, and a 3.43% yield. Check out ABBV's robust pipeline and long-term value.

JOURNAL NAME: Open Access Library Journal, Vol.12 No.6, June 13, 2025 ABSTRACT: Evaluating drug safety during pregnancy remains an ongoing clinical and pharmacological challenge due to ethical, ...